Delivery Order 36F79719D0108-36C24924F0132
Award Date
5/8/24
Potential Completion Date
5/18/24
Potential Value
$63K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Amicus Therapeutics US, LLC
Ultimate Awardee
Amicus Therapeutics, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order to Amicus Therapeutics US, LLC, a subsidiary of publicly traded biopharmaceutical company Amicus Therapeutics, Inc. The order, valued at $21,089.47, is for the specialty medication Galafold (migalastat) to treat Fabry disease. The delivery order was placed against Amicus Therapeutics US, LLC's five-year Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), a...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Amicus Therapeutics US, LLC, a subsidiary of publicly traded biopharmaceutical company Amicus Therapeutics, Inc. The order is for the delivery of the specialty medication Galafold (migalastat) to VHA facilities and service networks under the General Services Administration's Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The delivery order has a...
This is a Firm Fixed Price Delivery Order awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The $21,089.47 contract is to provide the pharmaceutical product Galafold (migalastat) to the VA. The contract is placed against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract administered by the General Services Administration. No set-aside designation is applied to the...
The Department of Veterans Affairs Veterans Health Administration awarded a $120,749 delivery order to Amicus Therapeutics US, LLC for pharmaceutical Galafold under the Pharmaceuticals and Drugs Federal Supply Schedule contract. Amicus Therapeutics, Inc., the parent company of Amicus Therapeutics US, will provide the medication to support Veterans Integrated Service Network 7's healthcare programs through January 2024 on a firm fixed price basis. No subcontractors or set aside designations...
The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a firm fixed-price delivery order to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., to provide the specialty medication GALAFOLD 123 MG. This delivery order, valued at $21,089.47, is being issued under the General Services Administration's Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. Amicus Therapeutics US, LLC has previously been awarded multiple delivery orders...
The Department of Veterans Affairs Veterans Health Administration awarded a $20,125 delivery order against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs GSA Schedule contract. Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., will provide GALAFOLD 123 MG to Veterans Integrated Service Network 5 in Philadelphia, Pennsylvania between August 31 and September 6, 2023. The firm fixed price order is funded by VA-VHA to support its mission of providing healthcare...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a $60,374.73 delivery order to Amicus Therapeutics US, LLC under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The one-month order is for an emergency purchase of Galifold, a medication used to treat adult patients with a rare disease called Fabry disease. As the lead agency serving veterans, the VA aims to ensure former military personnel and their families...
The Department of Veterans Affairs Veterans Health Administration awarded a $20,125 delivery order against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs GSA Schedule contract. Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., will provide GALAFOLD 123 MG to Veterans Integrated Service Network 5 in Philadelphia, Pennsylvania from December 6-8, 2023. The firm fixed price order supports the VA's mission to provide quality healthcare to veterans through its Veterans...
The Department of Veterans Affairs Veterans Health Administration awarded a $20,125 delivery order to Amicus Therapeutics US, LLC for GALAFOLD 123 MG. Amicus Therapeutics US, LLC is a subsidiary of Amicus Therapeutics, Inc., which will provide the pharmaceutical products under a Pharmaceuticals and Drugs schedule (FSS-61-IB) master agreement. Performance will occur in Philadelphia, Pennsylvania over a period of five days beginning November 8, 2023. As the funding agency, the VA-VHA will...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a $18,888.46 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Amicus Therapeutics US, LLC for an emergency buy of Galafold (migalastat). As the parent company, Amicus Therapeutics, Inc. will support product delivery. Performance will occur in Philadelphia, Pennsylvania. This schedule allows federal agencies to procure a wide range of pharmaceutical...